BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7461859)

  • 1. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
    Lee CS; Marbury TC; Benet LZ
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
    Wang LH; Lee CS; Majeske BL; Marbury TC
    Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of primidone elimination by uremic patients.
    Lee CS; Marbury TC; Perchalski RT; Wilder BJ
    J Clin Pharmacol; 1982 Jul; 22(7):301-8. PubMed ID: 7107978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
    Lee CS; Wang LH; Marbury TC; Bruni J; Perchalski RJ
    Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis clearance of chloroquine in uremic patients.
    Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
    Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis of theophylline in uremic patients.
    Lee CS; Marbury TC; Perrin JH; Fuller TJ
    J Clin Pharmacol; 1979 Apr; 19(4):219-26. PubMed ID: 438357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide method for evaluating the performance of hemodialysis in vivo.
    Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
    Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
    Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
    Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of phenytoin by hemodialysis in uremic patients.
    Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H
    JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on kinetics of acetaminophen elimination by anephric patients.
    Oie S; Lowenthal DT; Briggs WA; Levy G
    Clin Pharmacol Ther; 1975 Dec; 18(6):680-6. PubMed ID: 1204276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis of phenytoin in a uremic patient.
    Adler DS; Martin E; Gambertoglio JG; Tozer TN; Spire JP
    Clin Pharmacol Ther; 1975 Jul; 18(1):65-9. PubMed ID: 1149364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of felodipine in chronic hemodialysis patients.
    Buur T; Larsson R; RegÄrdh CG; Aberg J
    J Clin Pharmacol; 1991 Aug; 31(8):709-13. PubMed ID: 1880229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
    Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
    Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.